TLDR David Sacks said he divested key holdings before joining the administration in January. Sacks shared a legal letter stating he received two separate ethics clearances. The NYT article alleged Sacks advanced policies that helped tech associates. Sacks said five NYT reporters spent five months on the investigation. David Sacks, who serves as the White [...] The post David Sacks Denies Conflict Claims Over AI and Crypto White House Role appeared first on CoinCentral.TLDR David Sacks said he divested key holdings before joining the administration in January. Sacks shared a legal letter stating he received two separate ethics clearances. The NYT article alleged Sacks advanced policies that helped tech associates. Sacks said five NYT reporters spent five months on the investigation. David Sacks, who serves as the White [...] The post David Sacks Denies Conflict Claims Over AI and Crypto White House Role appeared first on CoinCentral.

David Sacks Denies Conflict Claims Over AI and Crypto White House Role

TLDR

  • David Sacks said he divested key holdings before joining the administration in January.
  • Sacks shared a legal letter stating he received two separate ethics clearances.

  • The NYT article alleged Sacks advanced policies that helped tech associates.

  • Sacks said five NYT reporters spent five months on the investigation.


David Sacks, who serves as the White House AI and crypto czar, rejected a New York Times article published November 30 that alleged conflicts of interest related to his government duties. In a public response, Sacks claimed the story was based on disproven allegations and said he met all ethics requirements when joining the administration.

Sacks posted a statement to X on Sunday, arguing that the Times reporters sought to build a narrative despite a lack of evidence. He added that five journalists spent several months examining his activities and investments, but failed to prove wrongdoing.

Sacks said he hired the defamation law firm Clare Locke during the reporting process. The firm sent a detailed letter to the New York Times that challenged the article’s content and conclusions.

The letter stated that Sacks filed all required financial disclosures and received two ethics letters—one for AI and another for cryptocurrency—from the U.S. Office of Government Ethics. It argued that neither the agency nor other officials raised any ethics concerns during his time in the administration.

Sacks’ legal team also disputed the idea that he failed to disclose remaining investments. They said he followed all required divestment procedures before assuming his role and that his portfolio was reviewed.

The letter said, “Mr. Sacks complied with all steps the [U.S. Office of Government Ethics] found necessary to address any potential conflicts.”

Disputed Allegations on Policy and Access

The New York Times article titled “Silicon Valley’s Man in the White House Is Benefiting Himself and His Friends” accused Sacks of using his position to promote policies that may favor his past tech investments. These included easing export restrictions on chips and promoting the GENIUS Act, which could benefit a portfolio company.

Other claims in the article included his role in a chip-related deal with the United Arab Emirates and how his White House role increased visibility for his “All-In” podcast.

Sacks denied all of these allegations. He said that one of the article’s claims was based on a fabricated dinner with a tech executive. He also stated that the Times adjusted its narrative repeatedly when prior accusations were disproven.

David Sacks Statement Urges Full Transparency

In his post, Sacks also made public the letter from Clare Locke. He said the document would give readers full context on his exchanges with reporters. The letter accused the Times of presenting a selective and misleading version of events.

It further rejected any suggestion that Sacks influenced government procurement or promoted companies in which he had financial interests. The letter said such claims were unsupported and, in some cases, “completely made up.”

Sacks concluded his statement by saying the article was the product of a failed effort to uncover wrongdoing where none existed

The post David Sacks Denies Conflict Claims Over AI and Crypto White House Role appeared first on CoinCentral.

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26